אנדרוג'ל 50 מג
cts ltd - testosterone - ג'ל - testosterone 0.05 mg/sachet - testosterone - testosterone - testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
אנדרוג'ל 50 מג
cts ltd - testosterone - ג'ל - testosterone 0.05 g/dose - testosterone
אנדרוג'ל 50 מג
cts ltd - testosterone - ג'ל - testosterone 0.05 g/dose - testosterone
אוטרוגסטן 200
cts ltd - progesterone micronized - קפסולות - progesterone micronized 200 mg - progesterone - progesterone - vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indication, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy. vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).
אוטרוגסטן 100
cts ltd - progesterone - קפסולות - progesterone 100 mg - progesterone
אוטרוגסטן 200
cts ltd - progesterone micronized - קפסולות - progesterone micronized 200 mg - progesterone
אסטרוג'ל
cts ltd - estradiol - ג'ל - estradiol 0.06 %w/w - estradiol - estradiol - hormonal replacement therapy for the treatment of symptoms associated with estrogen deficiency in menopausal women. prevention of postmenopausal osteoporosis in women with an increased risk for osteoporotic fractures and presenting intolerace or a contraindication to others treatments indicated in the prevention of osteoporosis.
אוטרוגסטן 100
cts ltd - progesterone - קפסולות - progesterone 100 mg - progesterone - progesterone - vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indications, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy.
רזין
cts chemical industries ltd, israel - phentermine as resinate - קפסולות - phentermine as resinate 15 mg - phentermine - phentermine - for the treatment of severe obesity that has not responded to an appropriate diet - a minimal body mass index of 30 kg/m2 is required.
רדיאן b מאסז'
devries & co. ltd - camphor; capsicum oleoresin; menthol; methyl salicylate - קרם - menthol 2.54 %w/w; camphor 1.43 %w/w; capsicum oleoresin 0.005 %w/w; methyl salicylate 0.42 %w/w - preparations with salicylic acid derivatives - relief of rheumatic pains and mild muscle pains.